Gadoxetate dynamic contrast-enhanced MRI (DCE-MRI) seems promising for non-invasive quantification of liver function. Here we tested the reproducibility of gadoxetate DCE-MRI at four MRI sites using an acute clinical dose of the antibiotic rifampicin. We found significant differences between sites in maximum relative enhancement (RE) in vehicle treated rats. However, highly significant differences in maximum RE between vehicle and rifampicin treated rats was detected at all sites. To our knowledge this is the first multicenter preclinical reproducibility study of an imaging biomarker.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords